Skin and Injection Site Reactions on GLP-1 Medications: How Common, Which Drug, and What to Do About It
GLP-1 injection site reactions and skin complaints made up 31 percent of 442,567 adverse event reports across six agents in a 2026 review, with pooled randomized trials showing a 3.55-fold higher risk than comparators. Almost all of these reactions are…
GLP-1 Agonist Clinical Evidence: Dining Out Guide
The GLP-1 dining out guide highlights how GLP-1 receptor agonists alter appetite and social eating behaviors. Patients often experience reduced portion sizes and changed food preferences. Understanding these effects helps improve adherence and…
Clinical Evidence on Semaglutide and Hair Loss
Semaglutide hair loss clinical evidence highlights a potential link between this GLP-1 receptor agonist and telogen effluvium. This side effect is generally temporary and related to rapid weight loss. Clinicians should counsel patients on this risk to…